Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial

TRION trial collaborators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Engineering & Materials Science